Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-21-025611
Filing Date
2021-07-26
Accepted
2021-07-26 16:05:38
Documents
2

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A ny20000032x1_defa14a.htm DEFA14A 63189
2 logo_brooklyn.jpg GRAPHIC 53677
  Complete submission text file 0001140361-21-025611.txt   138259
Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-11460 | Film No.: 211114157
SIC: 2834 Pharmaceutical Preparations